Milk-Alkali syndrome induced by H1N1 influenza vaccine

Saudi J Kidney Dis Transpl. 2017 Jul-Aug;28(4):912-915.

Abstract

Milk-Alkali syndrome (MAS) consists of a triad of hypercalcemia, metabolic alkalosis, and acute renal failure. We hereby report a 75-year-old Indian gentleman who presented to our emergency department with a history of generalized weakness and easy fatigability. Investigations were consistent with MAS secondary to calcium carbonate and calcitriol treatment to prevent osteoporosis, aggravated by H1N1 influenza vaccine. The patient was treated with hemodialysis and zoledronate. To our knowledge, this is the first reported case of such association in the literature.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Biomarkers / blood
  • Bone Density Conservation Agents / adverse effects
  • Calcitriol / adverse effects
  • Calcium / blood*
  • Calcium Carbonate / adverse effects
  • Humans
  • Hypercalcemia / blood
  • Hypercalcemia / chemically induced*
  • Hypercalcemia / diagnosis
  • Hypercalcemia / therapy
  • Influenza A Virus, H1N1 Subtype / immunology*
  • Influenza Vaccines / administration & dosage*
  • Influenza Vaccines / immunology
  • Male
  • Renal Dialysis
  • Risk Factors
  • Treatment Outcome
  • Up-Regulation

Substances

  • Biomarkers
  • Bone Density Conservation Agents
  • Influenza Vaccines
  • Calcitriol
  • Calcium Carbonate
  • Calcium